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Summary
Objective: In this study, we investigated the relationship between fascioliasis and serum mal-
ondialdehyde (MDA) levels, superoxide dismutase (SOD), catalase, and glutathione peroxidase
(GPx) activities. We also investigated whether there are significant differences in MDA levels and
antioxidant enzymatic activities between acute and chronic fascioliasis.
Methods: Forty fascioliasis patients who were diagnosed by ES-ELISA positivity were included in
this study. The patients were classified as 18 with acute and 22 with chronic fascioliasis.
Results: In patients with fascioliasis, levels of MDAwere statistically higher and erythrocyte SOD
and GPx activities were statistically lower than in healthy controls. MDA levels were found to be
higher in patients with acute fascioliasis than in patients with chronic fascioliasis although MDA
levels were significantly higher in patients with chronic fascioliasis than in controls. There was no
statistically significant difference between the two groups for the antioxidant enzyme activities.
Conclusion: The results of this study may indicate that fascioliasis produces specific effects on
the antioxidant defense mechanisms due to its inflammatory character. Our results also allow us
to suggest that oxidative stress has an important role in the pathogenesis of fascioliasis and the
persistence of this oxidative stress can be one of the underlying factors in the pathogenesis of the
chronic disease.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.* Corresponding author. Tel.: +90 2462112081;
fax: +90 2462371762.
E-mail address: selcuk@med.sdu.edu.tr (S. Kaya).
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doi:10.1016/j.ijid.2006.05.003Introduction
Fascioliasis is an infection of the bile ducts caused by Fasciola
hepatica, the liver fluke of sheep, cattle, and man.1 Fascio-
liasis is an important helminthic disease with an estimated
two million cases worldwide, and its incidence has appar-
ently increased since 1980.2 In our geographic region inPublished by Elsevier Ltd. All rights reserved.
252 S. Kaya et al.Turkey, recent prevalence rates of fascioliasis were 6.1% and
14.5% in patients with eosinophilia and chronic urticaria,
respectively.3,4 Fascioliasis can be classified as an acute or
chronic disease. The acute phase (parenchymal stage)
describes the fluke migration into the bile duct where para-
sites digest hepatic tissue and cause extensive parenchymal
destruction and immunologic and inflammatory reactions.
The chronic phase develops months after initial infection and
consists of inflammation and hyperplasia of the epithelium
caused by adult flukes residing in the bile ducts.5 In addition
to the mechanical effects on the bile ducts, excretory—
secretory (E—S) products such as proteases may contribute
to the tissue damage seen in fascioliasis.6 In addition, there is
evidence that infected tissue is under oxidative stress during
the parenchymal stage of the infection.7,8
Normal cellular metabolism involves the production of
reactive oxygen species (ROS).9 Low levels of ROS are vital
for proper cell functioning, while excessive in vivo genera-
tion of these products can adversely affect cell function-
ing.10,11 Production of ROS and lipid peroxidation (LPO)
occurs in clinical settings such as hepatic surgery, hemor-
rhagic shock, and parasitic infections.12,13 Malondialdehyde
(MDA) is one of the final products of LPO in human cells, and
an increase in ROS causes overproduction of MDA. Accord-
ingly, the MDA level is considered a surrogate marker of
oxidative stress.14,15 The major intracellular antioxidant
enzyme, superoxide dismutase (SOD), specifically converts
superoxide radicals to hydrogen peroxide,16 and catalase
and glutathione peroxidase (GPx) detoxify hydrogen perox-
ide towater.17 Reactive oxygen species including superoxide
anion, hydrogen peroxide, and hydroxyl radical act as sub-
cellular messengers in complex processes such as mitogenic
signal transduction, gene expression, and regulation of cell
proliferation when they are generated excessively or
when enzymatic and non-enzymatic defense systems are
impaired.18
There are a few studies on the association between
chronic fascioliasis and oxidative stress,19—21 but there is a
paucity of data on the blood antioxidant enzyme activities of
patients with acute or chronic fascioliasis. In addition, elu-
cidation of precise pathogenic mechanisms may have parti-
cular relevance for the treatment of fascioliasis. The aim of
this study was to measure the serum lipid peroxidation level
and SOD, GPx, and catalase activities in erythrocytes, and to
compare the results with those of healthy controls.Patients and methods
Patients
Forty patients with fascioliasis were included in this case—
control study. For each subject the diagnosis of fascioliasis
was established serologically using a modified enzyme-
linked immunosorbent assay (ELISA) prepared with ES anti-
gens in our laboratory or by finding eggs of Fasciola in
stools, and clinical and laboratory parameters were subse-
quently evaluated. There were 18 patients with acute
fascioliasis (10 male, 8 female; mean age 45 years) and
22 patients with chronic fascioliasis (11 male, 11 female;
mean age 47 years). There were no ethnic differences
between patients; nine subjects were from urban and 31were from rural areas. Besides duration of the disease,
patients were classified as having acute or chronic fascio-
liasis according to clinical, laboratory (liver enzymes, eosi-
nophilia, eggs in stools), and radiologic findings. Subjects
with symptoms 4 months were considered as having acute
infection, and patients with symptoms for >4 months were
deemed to have chronic infection. A control group con-
sisted of 40 healthy individuals (20 males, 20 females; mean
age 41 years) who were seronegative by ELISA assay for
fascioliasis, as well as seronegative for hepatitis B and C
viruses.
Patients with liver dysfunction, diabetes mellitus, cardiac
or renal failure, and those taking antioxidant or lipid-low-
ering therapy within the previous six months were excluded
from the study. This study was approved by the Medical
Faculty Ethics Committee of Suleyman Demirel University,
and written informed consent was obtained from all study
subjects and controls.
Blood collection and preparation of blood
samples
After an overnight fast, venous blood (10 mL) was taken
from an antecubital vein using a monovette blood collec-
tion system, inoculated into both non-anticoagulated and
anticoagulated tubes (containing sodium EDTA), and pro-
tected from light. Serum was obtained from 2 mL of blood
without anticoagulant. One mL of anticoagulated blood was
used for hematologic analysis. The remaining anticoagu-
lated blood was separated into plasma and erythrocytes by
centrifugation at 1500  g for 10 min at +4 8C. The ery-
throcyte samples were washed three times in cold isotonic
saline (0.9%, v/w) and then hemolyzed with a nine-fold
volume of phosphate buffer (50 mM, pH 7.4). After addition
of butylhydroxytoluol (4 mL per mL), hemolyzed erythro-
cyte samples were stored at 30 8C for <3 months pending
measurement of enzymatic activity. Serum samples
were used for immediate lipid peroxidation and all hema-
tological parameters were measured within six hours of
venipuncture.
Determination of lipid peroxidation levels
LPO (as malondialdehyde, MDA) levels in serum samples
were measured using the thiobarbituric acid reaction
method of Draper and Hadley.15 Quantification of thiobar-
bituric acid reactive substances was determined at
532 nm by comparing the absorption to the standard curve
of MDA equivalents generated by acid-catalyzed hydrolysis
of 1,1,3,3-tetramethoxypropane. Values of MDA were
expressed as nmol/mL.
Antioxidant enzyme assay
SOD activity determination: total (Cu—Zn and Mn) SOD (EC
1.15.1.1) activity was determined according to themethod of
Woolliams et al.22 The test is based on the inhibition of
nitroblue tetrazolium (NBT) reduction by the xanthine—
xanthine oxidase system as a superoxide generator. Activity
was assessed in the ethanol phase of the supernatant after
1.0 mL ethanol/chloroform mixture (5/3, v/v) was added to
the same volume of sample and centrifuged at 4000  g. One
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Table 1 Demographic features, serum MDA levels, and erythrocyte enzyme activities in fascioliasis patients and controls
Variable Fascioliasis (n = 40) Controls (n = 40) p value
Sex (M/F) 21/19 20/20 >0.05a
Age (years) 46 (41.7—50.2) 40.55 (37.2—43.8) >0.05b
MDA (nmol/mL) 1.42 (1.28—1.56) 0.20 (0.18—0.22) <0.001b
SOD (U/gHb) 1025.61 (861—1189) 1334.54 (1246—1422) 0.001b
GPx (U/gHb) 13.61 (12.5—14.6) 77.12 (69.3—84.8) <0.001b
Catalase (k/gHb) 24.89 (21.4—28.3) 21.31 (19—23.6) >0.05b
MDA, malondialdehyde; SOD, superoxide dismutase; GPx, glutathione peroxidase. Values expressed as means with 95% confidence intervals.
a Chi-square test.
b Student’s t-test.unit of SOD was defined as the enzyme amount causing 50%
inhibition in the NBT reduction rate. SOD activity was also
expressed as units per gram of hemoglobin in erythrocyte
samples.
Glutathione peroxidase activity determination: GPx (EC
1.6.4.2) activity was measured by the method of Paglia and
Valentine.23 The enzyme reaction in the tube, which contains
NADPH, reduced glutathione, sodium azide, and glutathione
reductase, was initiated by addition of hydrogen peroxide,
and the change in absorbance at 340 nm was monitored by a
spectrophotometer. Activity was given as units per gram of
hemoglobin in erythrocyte samples and all samples were
assayed in duplicate.
Catalase activity determination: catalase (EC 1.11.1.6)
activity was determined according to Aebi’s method.24 The
test is based on the determination of the rate constant (k) or
the H2O2 decomposition rate at 240 nm. Results were
expressed as k (s1) per gram hemoglobin. Assays were
performed at room temperature (25 8C).
Hemoglobin determinations: Hemoglobin values were
determined using an automated blood counter (Beckman
Coulter, Miami, USA).
Statistical analysis
All results are expressed as means with 95% confidence
intervals (CI). Statistical significance was evaluated usingTable 2 Demographic features and clinical and laboratory findin
Feature Acute fascioliasis (No. of patients/
Sex (M/F) (10/8)
Age (years) 44.8  12.6
Urban/rural 4/14
Common symptoms Abdominal pain (16/18)
Fever (9/18)
Weight loss (6/18)
Radiologic findings Tunnel-like, branching, hypodense
local and cystic lesions in the liver
parenchymal inflammation
Eosinophilia (18/18)
High ALT—AST (13/18—8/18)
High ALP—GGT (12/18—7/18)
Eggs in stools (0/18)
ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP,Student’s t, Chi-square, and one-way Anova tests and SPSS
(version 10.0; SPSS, USA) software package. A p value <0.05
was considered to be statistically significant.
Results
Demographic properties and means (95% CI) of MDA, SOD,
catalase, and GPx levels in fascioliasis patients and controls
are shown in Table 1. In patients with fascioliasis, levels of
MDAwere higher and erythrocyte SOD and GPx activities were
lower than in controls, and these differences were statisti-
cally significant ( p < 0.05). While the catalase activity was
higher in fascioliasis patients than in controls, the difference
was not statistically significant.
Demographic features and clinical and laboratory findings
of acute and chronic fascioliasis patients are shown in
Table 2. The most frequent symptoms in acute fascioliasis
patients were abdominal pain, fever, weight loss, and allergic
reactions, and in patients with chronic fascioliasis they were
abdominal pain, pruritis, and urticaria. Eosinophilia was
detected in only three chronic fascioliasis patients but in
all patients with acute fascioliasis. Furthermore, ALTand ALP
levels were elevated in 13 and 12 acute fascioliasis patients,
respectively, and GGTand ALP levels were elevated in six and
five of the chronic fascioliasis patients, respectively. In
addition, F. hepatica eggs were detected in four chronic
fascioliasis patients.gs in acute and chronic fascioliasis
total) Chronic fascioliasis (No. of patients/total)
(11/11)
46.9  14.2
(5/17)
Abdominal pain (15/22)
Pruritis (7/22)
Asymptomatic (3/22)
lesions;
;
Thickened wall of gallbladder;
dilated common bile duct; mass
in gallbladder
(3/22)
(2/22—2/22)
(5/22—6/22)
(4/22)
alkaline phosphatase; GGT, gamma glutamyltransferase.
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Table 3 Serum MDA and erythrocyte antioxidant enzyme activities in patients with acute and chronic fascioliasis
Level Acute fascioliasis (n = 18) Chronic fascioliasis (n = 22) Controls (n = 40)
MDA (nmol/mL) 1.61 (1.36—1.86) 1.26 (1.13—1.39) a 0.20 (0.18—0.22)b
SOD (U/gHb) 1028.02 (762—1293) 1023.62 (798—1248) c 1334.54 (1246—1422)d
GPx (U/gHb) 14.34 (13.1—15.5) 13.01 (11.3—14.6) c 77.12 (69.3—84.8)b
Catalase (k/gHb) 23.29 (18.1—28.4) 26.19 (21.1—31.2) c 21.31 (19—23.6) e
MDA, malondialdehyde; SOD, superoxide dismutase; GPx, glutathione peroxidase. Values expressed as means with 95% confidence intervals.
a p = 0.001 with acute fascioliasis.
b p < 0.001 with both acute and chronic fascioliasis.
c p > 0.05 with acute fascioliasis.
d p < 0.05 with both acute and chronic fascioliasis.
e p > 0.05 with both acute and chronic fascioliasis.Serum MDA, erythrocyte SOD, GPx, and catalase activities
in acute and chronic fascioliasis patients are shown in Table 3.
According to the duration of infection, MDA levels were
significantly higher in patients with acute fascioliasis com-
pared to patients with chronic fascioliasis ( p < 0.001),
although MDA levels were significantly higher in patients
with chronic fascioliasis compared to controls p < 0.01),
likely indicating the persistence of oxidative stress in the
chronic phase. There was no statistically significant differ-
ence between the two groups for the antioxidant enzyme
activities. However, using the one-way Anova test post hoc,
SOD and GPx activities were significantly lower in patients
with acute and chronic fascioliasis compared to controls
( p < 0.05 and p < 0.001, respectively).
Discussion
Inflammatory reactions lead to a decrease in erythrocyte
antioxidant enzyme activities of patients with fascioliasis and
other parasitic infections, while MDA levels in serum or
plasma increase in the presence of inflammation.25—29 In
the present study, erythrocyte antioxidant enzyme activities
were lower in study subjects compared to controls, while
serum MDA levels in patients with fascioliasis were higher
than in controls. These results likely reflect the inflammation
and oxidative stress that persists in the chronic phase of
fascioliasis. Others have similarly reported significant
improvement of SOD and GPx activities and in lipid peroxide
levels after antioxidant vitamin C and vitamin E supplemen-
tation plus triclabendazole compared to values after drug
therapy alone.20 These authors postulated that such findings
were due to the protective effects of these vitamins against
oxidative damage.
Oxidative cell injury may occur in the course of fascioliasis
as the consequence of tissue destruction produced by toxic
secretions of the flukes.30 In the acute phase of fascioliasis,
juvenile flukes cause localized or generalized toxic and
immunologic reactions that result in an increase in oxidative
stress and mechanical destruction of liver tissue and perito-
neum.5 There is evidence that the infected rat liver is under
oxidative stress during the parenchymal stage of infection.31
In the chronic stage, the fluke protects itself from immuno-
logic host responses by escaping into bile ducts. During this
period, inflammatory, necrotic, and fibrotic lesions develop
as a result of parasites migrating through the liver towards
the bile ducts. Hepatic fibrogenesis is also related to stimula-tion by lipid peroxidation of collagen synthesis in lipocytes
and activation of the release of profibrogenic cytokines by
Kupffer cells.19 In the course of fascioliasis, many E—S anti-
gens not yet fully identified may cause antigenic stimulation
in the host. It is also reported that E—S components of
F. hepaticamay also exert direct immune suppressive effects
through the activity of proteinases on immunoglobulin mole-
cules.32,33 However, the toxic and immunologic effects of
these antigens in the host have yet to be completely clarified.
Both catalase and GPx detoxify hydrogen peroxide to
water, although the latter appears to have more potent
activity.34 While GPx activities were lower in our patients
with fascioliasis compared to controls, catalase activities
were not significantly different between the groups,
although the reason for this is unclear.
Chronic asymptomatic fascioliasis may be characterized by
an absence of clinical features, parasite eggs in the stool,
elevated liver enzymes, eosinophilia, and radiographic find-
ings, and identified only by seropositivity. Asymptomatic
patients are often detected during contact screening and
although the precise frequency is not certain, asymptomatic
infection may constitute up to 20% of cases of chronic fascio-
liasis in some series.35 Our results suggest that biochemical
markers of oxidative stress may be diagnostically useful in
patients with chronic asymptomatic Fasciola infection.
In conclusion, in patients with fascioliasis the findings of
increased serum lipid peroxidation and decreased antioxi-
dant enzymes in erythrocytes indicate the presence of per-
sistent inflammation and oxidative stress. These results
support the hypothesis that there is an imbalance between
ROS production and antioxidant host defenses in inflamma-
tory fascioliasis disease. We suggest that oxidative stress may
be one of the factors underlying the pathogenesis of this
chronic parasitic infection.
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